This investigation pinpointed ZNF165, MXRA7, CEMIP, ARL4C, and CERCAM as promising prognostic indicators within the context of MSCs in BC, underscoring their potential as innovative therapeutic intervention points. Here, CEMIP is linked to breast cancer.